Rats that have sustained bilateral excitotoxic lesions of the ventral hippocampus (VH) as neonates develop behavioral abnormalities as adults (hyper-responsiveness to stress, diminished prepulse inhibition, and increased sensitivity to dopamine agonists), which resemble certain aspects of schizophrenia. Although this behavioral profile is thought to reflect dysregulation of the mesolimbic dopamine system, the precise neuroanatomical and neurochemical substrates that mediate the emergence of these abnormalities during brain maturation are unclear. In order to identify putative sites responsible for the development of behavioral abnormalities following neonatal lesions of the VH, we utilized the chronic neuronal activity marker DFosB. By comparison to sham lesioned animals, bilateral destruction of the VH elevated DFosB expression throughout the caudate putamen and neocortex of animals lesioned as neonates. These increases were not observed in rats lesioned as young-adults, suggesting that DFosB induction in the cortex of neonatally lesioned rats may be related to altered cortical neurodevelopment. Accumulating evidence implicates DFosB in mediation of the long-lasting effects of altered dopaminergic neurotransmission on behavior. The present findings are consistent with this proposal and suggest that elevated expression of DFosB identifies overactive neurons that may contribute to the enhanced sensitivity to stress and dopaminergic agonists of rats that have sustained bilateral ventral hippocampal lesions as neonates.
INTRODUCTION
The neurodevelopmental hypothesis of schizophrenia posits that clinical symptoms (which typically emerge in early adulthood) might be late consequences of an early defect in brain development (Walker and Neumann, 1996; Weinberger, 1987 Weinberger, , 1996 . Post-mortem cytoarchitectural abnormalities in the temporal lobe as well as the hippocampus and several other limbic regions suggestive of arrested neuronal migration during the second or third trimester of prenatal development provide the strongest evidence for developmental neuropathology in schizophrenia (Akbarian et al, 1993a, b; Arnold et al, 1991; Falkai and Bogarts, 1996; Jakob and Beckmann, 1986; Weinberger, 1996) . The neurodevelopmental hypothesis challenges commonly held assumptions that brain lesions lead to immediate impairments of function, which may improve with time, and that the possibility of functional recovery may be higher following certain types of lesions that occur early in life because of the plasticity of the immature brain (Kolb and Whishaw, 1989) . While these assumptions are supported by numerous studies on the effects of early brain lesions, it has been shown that early brain injuries can lead to worse functional outcomes than corresponding damage to adults. For instance, mature rats that have sustained unilateral hippocampal lesions as neonates, but not adults, display impaired spatial memory (vanPraag et al, 1996) . Furthermore, non-human primates that have received perinatal lesions of the dorsolateral prefrontal cortex perform well on a working memory task prior to maturity, but lose this ability in early adulthood (Goldman, 1971) . This latter observation indicates that early brain injury can result in impairment after a period of apparently normal functioning and development.
Bilateral excitotoxic lesions of the ventral hippocampus (VH) performed on 7-day-old rat pups result in animals that develop normally in many respects until puberty, when they begin to demonstrate features reminiscent of schizophrenia: hyper-responsiveness to stress, diminished prepulse inhibition of the acoustic startle response, and increased sensitivity to dopamine agonists and NMDA antagonists (Lipska et al, , 1995 Al-Amin et al, 2000) . This behavioral profile is presumed to reflect overactivity of the mesolimbic dopaminergic system and is ameliorated by antipsychotic drugs (Lipska and Weinberger, 1994) . However, the precise neuroanatomical and neurochemical substrates that mediate the emergence of these behaviors during development have yet to be established.
The fos and jun families of immediate-early genes (IEGs) encode transcription factors that alter target gene expression in response to extracellular stimuli (Morgan and Curran, 1989; Sheng and Greenberg, 1990) . Fos, the protein product of c-fos, has been used as a marker of neuronal activity in order to map functional pathways throughout the CNS (Dragunow and Faull, 1989; Morgan and Curran, 1991; Sagar et al, 1988) . However, c-fos mapping is limited by the fact that repeated neuronal stimulation results in a rapid loss of the acute c-fos response (Hope et al, 1994b; Rosen et al, 1994) . Another inducible transcription factor, DFosB, a truncated version of FosB generated by alternative splicing of the fosB transcript (Mumberg et al, 1991; Nakabeppu and Nathans, 1991) , has been found to have prolonged induction characteristics and may be a marker of chronic activation (Doucet et al, 1996; Hiroi et al, 1997; Mandelzys et al, 1997; Mumberg et al, 1991; Nakabeppu and Nathans, 1991) .
The goal of the present study was to compare DFosB expression in animals undergoing bilateral VH lesions as neonates with animals lesioned as young-adults in order to identify neuroanatomical sites that may be involved in the hyperdopaminergic behavioral profile observed in adulthood, after neonatal brain lesions.
MATERIALS AND METHODS

Animals and Experimental Protocols
One group of neonatal rats sustained bilateral excitotoxic VH lesions (see below) on postnatal day (PD) 7 while another group of rat pups underwent bilateral sham lesions. On PD25, animals were weaned, separated by lesion status, and grouped two to three to a cage until being killed on PD56 (7 weeks after the lesion or sham surgery described below). A third group consisted of young-adult rats that underwent bilateral excitotoxic VH lesions on PD42, while another eight young-adult rats sustained bilateral sham lesions. All of these animals were killed on PD70 (4 weeks after the sham or lesion surgery, which is described below). All animals were killed by deep anesthesia with pentobarbital (100 mg/kg, i.p.), immediately followed by intracardial perfusion with 150 ml of saline (0.9%) followed by 200 ml of 0.1 M phosphate buffer containing 4% paraformaldehyde. Brains were postfixed for several hours and then transferred to cold 10% sucrose in 100 mM sodium phosphate buffer for several days. Sections 20 mm thick were cut on a cryostat.
Hippocampal sections were stained with cresyl violet to verify the size and location of the lesion.
Neonatal Ventral Hippocampal Lesions
Bilateral lesions of the VH were performed on neonatal rats as described previously by . Pregnant Sprague-Dawley rats obtained at 12-15 days of gestation (Zivic-Miller Labs, Zelienople, PA) were housed individually in breeding cages with a 12 h light/dark cycle and fed ad libitum. Litters of four to eight male pups were formed. On PD7 (weight 15-18 g), pups were randomly assigned to lesion or sham status and anesthetized by hypothermia by placement on ice for 10-20 min. Pups were then taped to a platform fixed to a stereotaxic Kopf instrument and an incision was made in the skin overlying the skull. Bilateral VH lesions were made by infusing 0.3 ml of ibotenic acid (10 mg/ml; Sigma) (lesion) or artificial cerebrospinal fluid (CSF) (sham) through a Hamilton needle at the coordinates (in mm) anteroposterior (AP) À3.0, mediolateral (ML) 73.5, relative to bregma, and dorsoventral (DV) À5.0 mm, relative to the skull. Injections were made using an infusion pump at a rate of 0.15 ml/min (followed by 4 min of rest prior to withdrawing the needle). Pups were placed under warming lamps and then returned to their mothers.
Young-Adult Ventral Hippocampal Lesions
Young-adult VH lesions were performed on PD42 male Sprague-Dawley rats (weight 220-240 g) as described by Lipska et al (1992) . Briefly, rats were anesthetized with Equithesin (3 ml/kg, i.p.) and placed in a Kopf stereotaxic instrument. Ibotenic acid (6 mg/0.6 ml, over 3 min) (lesion) or an equal volume of artificial CSF (sham) was infused bilaterally (two injections on each side) through a 26-gauge stainless steel cannula at the coordinates (in mm) AP À4.4, ML 75.0 relative to bregma, and DV À8.0 and À6.0 mm relative to dura.
Antisera and Immunohistochemistry
FosB-like immunoreactivity was detected using two different affinity-purified rabbit polyclonal antibodies. The FosB(N) antibody was raised against amino acids 79-131 of the N-terminus of FosB and recognizes both FosB and DFosB. The FosB(C) antibody was raised against amino acids 245-315 of the C-terminus of FosB. Since the C-terminus is missing from DFosB, the FosB(C) antibody only recognizes FosB (Nakabeppu and Nathans, 1991; Nakabeppu et al, 1993) . Purification of the FosB(N) antibody by affinity chromatography of antisera on antigen columns and the establishment of its selectivity by Western blotting and immunoprecipitation experiments have been described previously (Nakabeppu and Nathans, 1991; Nakabeppu et al, 1993) . Immunohistochemistry was performed using a standard procedure described previously by Robertson and Fibiger (1992) . Sections 20 mm thick were washed in 0.02 M phosphate-buffered saline (PBS) containing 0.3% hydrogen peroxide for 10 min to block endogenous peroxidase activity. Sections were then washed three times in PBS and incubated in PBS containing 0.3% Triton X-100, 0.02% azide, and FosB(N) (1 : 1500) primary antisera for 48 h. Next, the sections were washed three times with PBS and incubated with biotin-labelled donkey anti-rabbit secondary antisera (1 : 200; Jackson Laboratories) for 16 h. The sections were washed three more times with PBS and incubated for 3 h with PBS containing 0.3% Triton X-100 and streptavidin-horseradish peroxidase (1 : 100; Amersham). After three further washes in PBS, the sections were rinsed in 0.1 M acetate buffer, pH 6.0. The reaction was visualized using a glucose oxidase-diaminobenzidinenickel method. The reaction was terminated by washing in acetate buffer, and the sections were mounted on chrome alum-coated slides. After drying, the sections were dehydrated through a graded series of alcohol and two changes of xylene, and coverslipped for microscopic observation.
Counting of Immunoreactive Cells
Images of FosB(N)-like immunoreactivity in the cortex, caudate putamen, and nucleus accumbens were taken using a Â 5 objective and an Axiocam HRc digital imaging camera and software package (AxioVision, Zeiss). Brain sections illustrating the areas (600 Â 800 mm) used for cell counts in the cortex, nucleus accumbens (core and shell), and caudate putamen (medial and lateral regions) are shown in Figure 1 . FosB(N)-like immunoreactivity was quantified in these regions by counting the number of immunoreactive nuclei using ScionImage Software. In all cases, cell counts were performed on 3-4 sections spaced approximately 120 mm apart by an observer unaware of the treatment condition.
Isolation of Nuclear Protein
Nuclear proteins were extracted from each rat cortex according to the methods previously described (Doucet et al, 1996) . Each cortex was homogenized using a dounce homogenizer (loose pestle, 15 strokes) in 1 ml of Buffer A (0.25 M sucrose, 0.05 M Tris-HCl (pH 6.8), 0.025 M NaCl, 4 mM MgCl 2 , 1 mM EGTA, and the following protease inhibitors added just before use: Roche Complete Protease Inhibitor tablet (Roche Applies Sciences, Laval, Quebec, Canada) and 1 mM PMSF). Samples were centrifuged at 11 000g for 20 s and resuspended in 250 ml of Buffer A containing 1% Triton X-100. Following an incubation for 5 min at 41C, samples were dounce homogenized (tight pestle, 20 strokes) and the nuclei were pelleted by centrifugation at 11 000g for 20 s. Each pellet was resuspended in 60 ml of Buffer B (0.75 M NaCl, 0.05 M HEPES (pH 7.9), 12.5% glycerol, 0.75 mM MgCl 2 , 0.5 mM EGTA, 5 mM dithiothreitol, plus protease inhibitors), vortexed, and incubated at 41C for 45 min. Nuclear extracts were collected following centrifugation at 13 000g for 15 min at 41C.
Western Blotting
Cortical nuclear protein extracts (20 mg) were separated on 10% SDS-polyacrylamide gels. Protein was then transferred to PVDF membranes, blocked for 1 h in 1% milk powder in Tris-buffered saline containing 0.05% Tween 20 (TBS-T), and incubated in polyclonal anti-FosB antibody (1 : 200; Santa Cruz) overnight at 41C. Membranes were then rinsed in TBS-T and incubated in a horseradish peroxidaseconjugated anti-rabbit antibody (1 : 5000; BD Transduction Laboratories) for 1 h at room temperature. Following washes in TBS-T, the membranes were incubated with ECL-plus reagent (Amersham Biosciences, Quebec, Canada) and scanned using a Storm imaging system (Amersham Biosciences). Membranes were then stripped according to the manufacturer's recommendations (ECL-plus reagent, Neonatal VH lesion increases DFosB KJ Powell et al
Amersham Biosciences), incubated in 5% milk powder in TBS-T for 10 min, and incubated in monoclonal anti-b-actin antibody (Sigma) overnight at 41C. Following washes in TBS-T, membranes were incubated in a peroxidaseconjugated anti-mouse antibody (1 : 10 000; Vector Laboratories) for 1 h at room temperature, washed in TBS-T, incubated with ECL-plus reagent, and rescanned using the Storm imaging system. ImageQuant software (Amersham Biosciences) was used to determine the optical density of protein bands and all data were normalized to the expression of b-actin.
Statistical Analysis
The number of FosB(N)-immunoreactive nuclei observed in the neonate sham, neonate lesion, young-adult sham, and young-adult lesion groups were compared using a two-way analysis of variance (ANOVA) followed by a Bonferroni post hoc test, with Age (neonate and young-adult) and Lesion Status (sham and lesion) as independent variables. Results from Western blot experiments for the expression of FosB and DFosB in sham and lesioned neonatal and young-adult animals were also compared using a two-way ANOVA and Bonferroni post hoc test (GraphPad Prism version 4.00 for Windows, GraphPad Software, San Diego, California, USA).
RESULTS
Verification of the Lesion
Representative cresyl violet-stained sections from adult rats that received bilateral VH lesions either as neonates or young-adults are shown in Figure 2 . Injection of ibotenic acid into the VH of neonatal and young-adult rats produced a lesion of comparable size characterized by neuronal loss and atrophy (Figure 2b and d). These lesions were largely restricted to the VH. Animals that displayed damage in the dorsal hippocampus were not included in the study. Animals that received sham lesions either as neonates or young-adults did not show any visible damage to the hippocampus (Figure 2a and c).
Effects of Bilateral Ventral Hippocampal Lesions on DFosB-Like Immunoreactivity in the Cortex
Representative photomicrographs of FosB(N) immunoreactivity in the cortex of animals lesioned as neonates or young-adults are shown in Figure 3 . In adult animals that received sham lesions either as neonates or young-adults, basal expression of FosB(N) immunoreactivity was low, with few FosB(N)-immunoreactive neurons observed in superficial and deep layers of the cortex (Figure 3a and c) . At 7 weeks after bilateral ibotenic acid lesions of the VH of neonatal rats, there was a marked increase in the number of immunoreactive neurons detected with the anti-FosB(N) antibody throughout the entire neocortex (Figure 3a) . Representative pictures of the sensorimotor cortex show that FosB(N) immunoreactivity was highest in deep (layers V and VI) and superficial cortical layers (II and III) of animals lesioned bilaterally in the VH as neonates (PD7; Figure 3b ). Animals lesioned on PD42 (young-adult) did not show induction in the cortex 4 weeks after surgery (Figure 3d ). Very few immunoreactive neurons were detected by the FosB(C) antibody in all of the four groups in this experiment. Fidelity of the FosB(C) antibody was confirmed by robust immunostaining in animals that had received acute injections of clozapine or haloperidol (results not shown) and thereby served as FosB induction controls. This indicates that the observed anti-FosB(N) immunoreactivity was due to DFosB since FosB levels were below the limits of detection with the FosB(C) antibody. The term DFosB-like immunoreactivity will be used from this point on to describe immunoreactivity detected with the FosB(N) antibody.
Cell counts for DFosB-immunoreactive neurons in the cortex revealed a significant effect of Lesion ( To further confirm that the increased immunostaining observed with the FosB(N) antibody resulted from increased expression DFosB and not FosB, Western blot analysis was performed on nuclear extracts from cortical tissue. As shown in Figure 5a and b, the pan-FosB antibody recognized bands ranging from 33 to 37 kDa, representing DFosB and its more stable phosphorylated isoforms, and a band at 47 kDa, representing FosB. Following normalization of the optical densities of these bands to that of b-actin, quantification of DFosB revealed a significant effect of Lesion (F 1,18 ¼ 9.764, Po0.01), Age (F 1,18 ¼ 4.611, Po0.05), and an interaction of Age Â Lesion (F 1,18 ¼ 6.735, Po0.02). There was no significant effect of either Lesion or Age on FosB expression. Adult animals that received ibotenic acid as neonates showed a significant increase in the expression of DFosB as compared to sham controls (Figure 5a and d) . Consistent with our immunohistochemical findings, there was no difference in the levels of FosB between neonatal sham-and ibotenic acid lesioned animals (Figure 5a and c) .
Quantification of the optical densities of DFosB and FosB bands, following normalization to b-actin, revealed no significant differences between young-adult sham and lesioned animals (Figure 5b-d) .
Effect of Bilateral Ventral Hippocampal Lesions on DFosB-Like Immunoreactivity in the Caudate Putamen
Similar to our findings in the cortex, few DFosB-immunoreactive neurons were observed in the caudate putamen of adult animals that received ibotenic acid or sham lesions as young-adults (Figure 6c and d) . DFosB immunoreactivity was increased only in animals lesioned with ibotenic acid as neonates (Figure 6b ). Animals lesioned with ibotenic acid as young-adults did not show this induction 4 weeks after surgery (Figure 6d ). Cell counts for DFosB-immunoreactive neurons in the medial and lateral caudate putamen are given in Figure 7a and b. In the medial caudate putamen, there was a significant effect of Lesion (F 1,15 ¼ 45.52, Po0.0001), Age (F 1,15 ¼ 59.60, Po0.0001), and an interaction of Age Â Lesion (F 1,15 ¼ 42.13, Po0.0001). Post hoc analysis revealed that animals lesioned with ibotenic acid as neonates displayed significantly more DFosB-like immunoreactive neurons compared to sham lesioned controls with counts of 457.77111.8 and 72.2720.5, respectively (Figure 7a ). DFosB expression was not significantly elevated in animals lesioned as young-adults compared to sham lesioned controls with counts of 43.9733.5 and 36.4728.3, respectively (Figure 7a ). In the lateral caudate putamen, there was also a significant effect of Lesion (F 1,15 ¼ 10.29, Po0.01), Age (F 1,15 ¼ 9.27, Po0.01), and an interaction of Age Â Lesion (F 1,15 ¼ 7.29, Po0.05). Post hoc analysis indicated that animals lesioned with ibotenic acid as neonates displayed more DFosB-like immunoreactive cell in the lateral region of the caudate putamen when compared to 
Effect of Bilateral Ventral Hippocampal Lesions on DFosB-Like Immunoreactivity in the Nucleus Accumbens
In all groups, a greater number of DFosB-immunoreactive neurons were observed in the core as compared to the shell region of the nucleus accumbens (Figure 8 ). Regardless of whether animals were sham treated or lesioned as neonates, a greater number of DFosB neurons were detected in adult animals that received these treatments as neonates as compared to young-adults (Figures 7c, d, and 8) . Unlike the cortex and caudate putamen where neonatal lesioned animals displayed higher levels of DFosB expression, cell counts revealed that there was not a significant effect of Age, Lesion, or an interaction of Age Â Lesion in the core of the nucleus accumbens among the four treatment groups. Lastly, in the shell region, there was a significant effect of Age (F 1,16 ¼ 5.68, Po0.05) but not of Lesion or Age Â Lesion, suggesting that animals sham treated or lesioned as neonates display increased DFosB levels compared to animals that received either treatment as young-adults. No differences were found between individual groups when post hoc comparisons were performed.
DISCUSSION
The major finding of the present study was that adult rats given VH lesions as neonates display a widespread and dramatic increase in the expression of DFosB-like proteins in the cortex, caudate putamen, and nucleus accumbens. This elevation of DFosB expression in the cortex and caudate putamen emerges following a maturation period since it was observed only in animals lesioned as neonates and not as young-adults. This result suggests that chronic activation of neurons, at least in terms of gene expression, in the cortex and caudate putamen may be a specific neurodevelopmental consequence of the neonatal VH lesion. 
Functional Implications of DFosB Expression
DFosB-like proteins and chronic Fos-related antigens (FRAs) are long half-life transcription factors, which are induced in the brain after a variety of chronic stimuli including repeated electroconvulsive shock (Hope et al, 1994a) , kainate-induced status epilepticus (Bing et al, 1996; Mandelzys et al, 1997) , chronic administration of cocaine (Hope et al, 1994b; Moratalla et al, 1996; Nye and Nestler, 1996) , morphine (Nye and Nestler, 1996) , nicotine (Pich et al, 1997) , neuroleptics (Doucet et al, 1996; Hiroi and Graybiel, 1996; Nye et al, 1995; VahidAnsari et al, 1996) , and dopaminergic deafferentation of the striatum (Doucet et al, 1996; Jian et al, 1993) . It is now well established that chronic FRAs are in fact variants of DFosB (Chen et al, 1997; Hiroi et al, 1997; Mandelzys et al, 1997) . The hypothesis that overstimulated cells convert FosB to DFosB as part of a cellular transcriptional 'braking system' is based, in part, on transfection assays where DFosB inhibited activator protein-1 (AP-1, formed by the dimerization of Fos and Jun proteins) transcriptional activity in a dominant-negative fashion (Nakabeppu and Nathans, 1991) . Because DFosB has low transactivating activity, likely due to the loss of the heptaproline sequence that functions as an activation domain in FosB (Nakabeppu and Nathans, 1991) , but retains the ability to both dimerize with other members of the Jun family of proteins (to form AP-1 complexes) and to bind to the AP-1 site, it competes with Fos and Jun transcription factors to form less transcriptionally active AP-1 complexes (for review see Hughes and Dragunow, 1995) .
Recently, the effects of DFosB expression were examined in vivo using transgenic mice in which DFosB can be selectively induced in the brain. These studies demonstrate that short-term DFosB expression decreases the expression of genes by acting as a transcriptional repressor of the AP-1 site, but following prolonged expression, DFosB acts as a transcriptional activator at AP-1 sites (McClung and Nestler, 2003) . One of the genes activated by DFosB is CaM-KinaseII that phosphorylates the transcription factor CREB thereby reducing the transcriptional activity of CREB and the expression of target genes (McClung and Nestler, 2003) . DFosB also upregulates the expression of many genes that encode inhibitory ion channels or are associated with these proteins (McClung and Nestler, 2003) . Further evidence that DFosB expression serves to reduce neuronal activity comes from the fact that repeated electroconvulsive shock both induces DFosB (Hope et al, 1994a) and increases resistance to subsequent seizures. Furthermore, fosB knockout mice are actually predisposed to seizures (Gruda et al, 1996; Mandelzys et al, 1997) . Cumulatively, these studies provide support for a dual regulatory role of DFosB over gene expression that changes over time and that ultimately serves to decrease cellular overactivity.
While a variety of mechanisms can be postulated to account for the widespread DFosB induction resulting from neonatal VH lesions, the precise pathways and neurochemical events underlying this cortical activation are not known. It has been shown that animals with neonatal VH lesions display profound morphological, biochemical, and electrophysiological alterations in the neurons in the medial prefrontal cortex (mPFC). Morphological changes include decreased dendritic length and spine density of pyramidal neurons (Lipska et al, 2001) . Electrophysiological studies indicate that the prefrontal cortical neurons of adult rats lesioned as neonates in the VH are hyper-responsive to the stimulation of the VTA (O'Donnell et al, 2002) . A decrease in the mRNA expression for the enzyme responsible for GABA synthesis (GAD67) has been found in the mPFC following lesion of the VH , suggesting that attenuated GABAergic inhibition may contribute to the enhanced sensitivity of cortical neurons to VTA stimulation. Further evidence for the alterations in the mPFC following neonatal VH lesion comes from a study demonstrating that subsequent lesion of the mPFC as adults normalizes hyperdopaminergic behaviors observed in these animals (Lipska et al, 1998) . Thus, early damage in the VH appears to disrupt normal cortical function and contribute to the dysregulation of subcortical dopamine neurotransmission. Prolonged increases in cortical activity may result in elevated expression of DFosB and reflect an attempt to compensate for excessive activation of the cortex.
It has been well documented that adult rats that have sustained neonatal VH lesions show an altered response to stress. These animals demonstrate a hyper-responsiveness to stress ) that may be mediated by an altered neuroendocrine response to stress (Chrapusta et al, 2003; Mitchell and Goldman, 2004) . It is thought that the VH modulates the hypothalamic-pituitary-adrenal axis, producing an inhibition of this pathway following stress (Herman et al, 1998; Mitchell and Goldman, 2004) . Interestingly, it has recently been shown that chronic stress increases the expression of DFosB in several of the brain regions in which we observed an increase in DFosB following neonatal VH lesions, such as the mPFC, caudate putamen, and nucleus accumbens (Perrotti et al, 2004) . It is therefore possible that VH lesions produce a state of enhanced responsiveness to stress resulting in comparable alterations in the activity or neuroendocrine and neuronal pathways that mediate stress-induced increase in DFosB expression.
Antipsychotic drugs ameliorate several of the behavioral abnormalities observed in the neonatal VH lesion model of schizophrenia. These drugs also increase the expression of FosB in many of the same brain structures that we have observed in this study (Atkins et al, 1999; Robertson et al, 2004; Rodriguez et al, 2001) . Despite these apparent similarities, there are several marked differences in both the pattern and magnitude of DFosB expression induced by neuroleptics and in the increase we observed following neonatal VH lesion. Firstly, typical neuroleptics increase DFosB primarily in lateral regions of the caudate putamen, while we observed a considerably greater elevation of the transcriptional regulating factor in the medial compared to the lateral aspect of dorsal caudate putamen. Secondly, chronic administration of atypical antipsychotics such as clozapine and olanzapine induces a small but significant elevation of DFosB immunoreactivity in the medial aspect of the caudate putamen that is located predominantly in patches (Grande et al, 2004) . By contrast, neonatal VH lesions produced a considerably larger (six-fold) elevation in the number of DFosB-immunoreactive neurons in the medial caudate putamen that appeared to be distributed evenly, suggesting that localization is not restricted to the striatal patches. Thirdly, the increases in cortical DFosB expression produced by chronic neuroleptic administration are modest (two-to three-fold) and occur chiefly in frontal and cingulate regions of the cortex (Rodriguez et al, 2001 ), while we observed considerably larger increases in immunoreactive neurons (18-fold) localized in both superficial and deep layers throughout the entire perimeter of the neocortex. Consequently, antipsychotic drugs and neonatal VH lesions appear to impact different populations of neurons in the caudate putamen and cortex to a greater degree.
Relationship to Clinical Findings
Accumulating evidence implicates the hippocampus (and other temporal lobe structures) as a site of pathology in schizophrenia (Weinberger, 1999 ; for review of structural changes, see Shenton, 1996) . Although the neuropathology of schizophrenia is obviously much more subtle than that produced by an ibotenic acid of the VH, there may in fact be a clinical correlate for the cortical overactivity suggested by the marked and widespread elevation of DFosB expression observed in the present study. Recent post-mortem studies of patients with schizophrenia have shown a reduction in GAD67 mRNA expression in cortex (Akbarian et al, 1995; Volk et al, 2000) as well as increased GABA-A receptor binding in the prefrontal and cingulate cortices (Benes et al, 1992 (Benes et al, , 1996 . Elevated GABA-A binding may reflect a compensatory response to decreased GABA synthesis designed to reverse excessive neuronal activity. More striking, however, is the laminar similarity between the cortical DFosB expression in our preclinical model and the pattern of GABA-A receptor upregulation observed in superficial and deep layers of the prefrontal cortex of schizophrenia patients, with the greater upregulation of both GABA-A and DFosB appearing to occur in lamina II (Benes et al, 1996) .
In summary, the results of the present study suggest that neonatal damage to the VH produces a prolonged overactivation of neurons located in the caudate putamen and superficial and deep layers of the cortex that may contribute to the abnormalities observed in this model of schizophrenia. The induction of DFosB expression in superficial and deep layers of the neocortex may indicate an attempt to normalize activity in these neurons. Since antipsychotics ameliorate several of the behavioral abnormalities observed in the neonatal VH lesion model as well as in schizophrenia and induce FosB and DFosB, their mechanism may be related to long-lasting changes in gene expression regulated by Fos proteins. It would be worthwhile to determine whether chronic antipsychotic administration alters the pattern of DFosB expression in the cortex, nucleus accumbens, and caudate putamen that we have observed in adult animals that have sustained bilateral VH lesions as neonates.
